日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Developing therapeutics for rare cardiovascular diseases

开发罕见心血管疾病的治疗方法

Lerman, Joseph B; Koeberl, Dwight D; Epstein, Shilpi; Roessig, Lothar; Stan, Rodica; Halley, Meghan; Owens, Anjali T; Greenberg, Barry; Alexander, Kevin M; Day, Sharlene M; Maurer, Mathew S; Adler, Eric D; Hernandez, Adrian F; Ashley, Euan A; Felker, G Michael

Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy

利用表型图谱分析射血分数降低的心力衰竭患者,以识别具有高残余风险的亚群:VICTORIA 子研究

Shah, Palak; Zheng, Yinggan; Pieske, Burkert; Melenovsky, Vojtech; Lam, Carolyn S P; Sliwa, Karen; Butler, Javed; Ezekowitz, Justin A; deFilippi, Christopher R; O'Connor, Christopher M; Sandhu, Roopinder K; Roessig, Lothar; Tromp, Jasper; Westerhout, Cynthia M; Voors, Adriaan A; Armstrong, Paul W

Cardiotropic AAV gene therapy for heart failure: a phase 1 trial

针对心力衰竭的心脏靶向性AAV基因疗法:一项I期试验

Henry, Timothy D; Chung, Eugene S; Alvisi, Monica; Sethna, Ferzin; Murray, David R; Traverse, Jay H; Roessig, Lothar; Roberts, Luke; Reddy, Swarna; Chen, Youjun; Ozkan, Tugba Guven; Webb, Stacy; Mittal, Monika; Ervin, Leigh; Sadek, Hesham; Mikhail, Sheila; Haghighi, Kobra; Jiang, Canwen; Samulski, R Jude; Kranias, Evangelia G; Tretiakova, Anna P; Hajjar, Roger J

Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat

维利西呱的临床药代动力学和药效学特征

Fritsch, Achim; Meyer, Michaela; Blaustein, Robert O; Trujillo, Maria E; Kauh, Eunkyung; Roessig, Lothar; Boettcher, Michael; Becker, Corina

Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY-HFpEF trial

加速度计与其他活动测量方法在射血分数保留型心力衰竭中的比较:VITALITY-HFpEF试验

Butler, Javed; Khan, Muhammad Shahzeb; Gasior, Tomasz; Erickson, Tyler R; Vlajnic, Vanja; Kramer, Frank; Blaustein, Robert O; Goldsbury, David; Roessig, Lothar; Lam, Carolyn S P; Anstrom, Kevin J; Armstrong, Paul W

Framework of the strengths and challenges of clinically integrated trials: An expert panel report

临床整合试验的优势与挑战框架:专家组报告

Peters, Anthony E; Jones, W Schuyler; Anderson, Brian; Bramante, Carolyn T; Broedl, Uli; Hornik, Christoph P; Kehoe, Lindsay; Knowlton, Kirk U; Krofah, Esther; Landray, Martin; Locke, Trevan; Patel, Manesh R; Psotka, Mitchell; Rockhold, Frank W; Roessig, Lothar; Rothman, Russell L; Schofield, Lesley; Stockbridge, Norman; Trontell, Anne; Curtis, Lesley H; Tenaerts, Pamela; Hernandez, Adrian F

Paradigmatic and syntagmatic effects of information status on prosodic prominence - evidence from an interactive web-based production experiment in German

信息状态对韵律显著性的范式效应和句法效应——来自德语交互式网络生成实验的证据

Lorenzen, Janne; Roessig, Simon; Baumann, Stefan

Challenges with the kinematic analysis of neurotypical and impaired speech: Measures and models

神经典型和障碍言语的运动学分析面临的挑战:测量和模型

Mücke, Doris; Roessig, Simon; Thies, Tabea; Hermes, Anne; Mefferd, Antje

Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study

阴性判定心力衰竭事件的临床意义:来自 VICTORIA 研究的数据

Felker, G Michael; North, Rebecca; Mulder, Hillary; Jones, W Schuyler; Anstrom, Kevin J; Patel, Mahesh J; Butler, Javed; Ezekowitz, Justin A; Lam, Carolyn; O'Connor, Christopher M; Roessig, Lothar; Hernandez, Adrian F; Armstrong, Paul W

Impact of COVID-19 on Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory

COVID-19 对心力衰竭临床试验的影响:来自心力衰竭合作研究的见解

Bhatt, Ankeet S; Dimond, Matthew; Fiuzat, Mona; Vaduganathan, Muthiah; Vardeny, Orly; Divanji, Punag; Komtebedde, Jan; Lefkowitz, Martin P; Nkulikiyinka, Richard; Petersson, Magnus; Roessig, Lothar; Schaber, Daniel; O'Connor, Christopher M; Solomon, Scott D